Alan Douglas
Human Clinical Trials By Geron Corp
Started by
alan
, Jul 30 2010 04:36 PM
4 replies to this topic
#1
Posted 30 July 2010 - 04:36 PM
I think this is tremendous news. This organisation has spent hundreds of millions of dollars developing a wide range of stem cell technologies. If you go to their website (Google Geron) you will see that their products are designed for several neurological disorders including spinal-cord injury, multiple sclerosis and alzheimers. The trials however will be for spinal-cord injury. These are the people who were obstructed by the George Bush administration. The bad news is that even if these trials go extremely well, they are just the first phase. Overall, we are still looking at 8 to 10 years for any sort of cure. Nevertheless, it bodes well for the future.
Alan Douglas
Alan Douglas
#3
Posted 31 July 2010 - 06:41 PM
-dani
#4
Posted 17 August 2010 - 04:32 PM
Some bad news about Geron Corporation from the point of view of existing spinal cord injured individuals. My original posting at the top whilst accurate misses out something which has just been published on the Geron site. Unfortunately, their procedures will only work on people with new injuries. Once scarring has occurred, their product is ineffective. For more information please go to:
Clinical Program
However, I do not wish to say anything bad about Geron. Maybe, in a few years, anyone who experiences a spinal-cord injury will have the opportunity of a cure or partial cure. For me, this must be celebrated. Moreover, their products will hopefully impact on numerous other disabilities and diseases including diabetes, heart failure, osteoporosis etc.
Alan Douglas
Clinical Program
However, I do not wish to say anything bad about Geron. Maybe, in a few years, anyone who experiences a spinal-cord injury will have the opportunity of a cure or partial cure. For me, this must be celebrated. Moreover, their products will hopefully impact on numerous other disabilities and diseases including diabetes, heart failure, osteoporosis etc.
Alan Douglas
Edited by alan, 17 August 2010 - 04:41 PM.
#5
Posted 17 August 2010 - 07:10 PM
This study looks well thought out and sensibly conservative. It is also designed for showing maximum benefit in the group most likely to benefit. This is excellent strategy. There will be time enough to fail later, once the basic usefulness of their stem cells has been proven.
Look! It's a snail! It's a sloth! Able to creep short distances before lunch!
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users





Top








